CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Net income attributable to common shareholders		$ 37.8	$ 43.7
Adjustments to reconcile net income to net cash flows provided by operating activities:
Depreciation and amortization		18.5	19.0
Stock-based compensation expense		2.3	2.3
Deferred income taxes		0.2	3.1
Cash used for operating working capital		(50.8)	(28.7)
Other		1.5	(3.9)
Total provided by operating activities		9.5	35.5
Investing activities:
Capital expenditures		(12.5)	(4.0)
Total used for investing activities		(12.5)	(4.0)
Financing activities:
Dividends paid		(9.1)	0.0
Proceeds from stock options exercised		1.6	0.0
Payment of tax withholding on equity awards vested		(6.2)	0.0
Debt issuance costs		0.0	(4.0)
Proceeds from revolving credit facility		30.0	0.0
Repayment of revolving credit facility		(5.0)	0.0
Proceeds from term loan		0.0	350.0
Repayment of term loan		(0.7)	0.0
Net transfers to Crane		0.0	(392.6)
Total provided by (used for) financing activities		10.6	(46.6)
Effect of exchange rates on cash, cash equivalents and restricted cash		(7.9)	2.6
Decrease in cash, cash equivalents and restricted cash		(0.3)	(12.5)
Cash and cash equivalents at beginning of period		227.2	230.7
Cash, cash equivalents and restricted cash at end of period	[1]	226.9	218.2
Current restricted cash		0.1	0.0
Noncurrent restricted cash		6.2	0.0
Detail of cash used for operating working capital:
Accounts receivable		28.2	21.0
Inventories		(11.7)	(12.2)
Other current assets		(14.5)	(4.7)
Accounts payable		(16.3)	(13.9)
Accrued liabilities		(36.8)	(26.0)
U.S. and foreign taxes on income		0.3	7.1
Total		(50.8)	(28.7)
Supplemental disclosure of cash flow information:
Interest paid		9.2	7.4
Income taxes paid		8.7	6.1
Unpaid capital expenditures		$ 2.0	$ 1.4

[1] 1 Includes both current and non-current balances of restricted cash. Current restricted cash, included within “Other current assets” in our Unaudited Consolidated and Combined Condensed Balance Sheets, was $0.1 million and $0.0 million as of March 31, 2024, and March 31, 2023, respectively. Non-current restricted cash, included within “Other assets” in our Unaudited Consolidated and Combined Condensed Balance Sheets, was $6.2 million and $0.0 million as of March 31, 2024, and March 31, 2023, respectively.